Concepedia

Zhuoye Xie

ZX

Statistics

Publications

3

Citations

84

H-Index

3

Active since

2022

Affiliations

First Affiliated Hospital of University of South China(Current)

University of South China

University of Toronto

Zhuoye Xie is an author at First Affiliated Hospital of University of South China specializing in pharmacology, molecular oncology, and oncology.

ORCID

Publications per year

2022–2025

3

Publications

3

Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer

Qingyun Zhu, Qiuzi Dai, Lei Zhao et al. · Cell Death and Disease · 2024 · 38 citations · Full text

, , +17

Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop

Yingying Shen, Qingyun Zhu, Maoyu Xiao et al. · Cell Death and Disease · 2022 · 36 citations · Full text

, , +17

Optimizing electrical field stimulation parameters reveals the maximum contractile function of human skeletal muscle microtissues

Yekaterina Tiper, Zhuoye Xie, Arne D. Hofemeier et al. · American Journal of Physiology-Cell Physiology · 2025 · 10 citations · Full text

, , +17

1–3 of 3